Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; Chapter 1: Clinical Trials: Historical Aspects and Importance and New Drug Developments -- Chapter 2: The Definition of GCP -- Chapter 3: The Principles of GCP -- Chapter 4: The Drug Development Process and Evolution of Regulations -- Chapter 5: Planning Clinical Research -- Cha…
This extensively revised second edition is a unique and portable handbook focusing on clinical trials in surgery. It includes new educational materials addressing the rapid evolution of novel research methodologies in basic science, clinical and educational research. The underlying principles of cl…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
This multidisciplinary reference explores the concepts and realities of quality of life among cancer survivors in its physical, psychological, cognitive, social, and familial dimensions. Informed by a broad range of fields including genetics, psychiatry, nursing, dentistry, rehabilitation, and ethi…
Contents:; Introduction : the good, the bad, and the ugly -- Transforming both health and care -- Compassion and contentment : being heartful -- Values and excellences in nursing -- The art of reaffirming purpose -- A heavy heart hurts -- I know what I ought to do! -- Burnt out and seemingly heartl…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; Chapter 1 -- Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer -- Chapter 2 Monoclonal Antibody Therapy -- Chapter 3 Somatic Mutations and Immunotherapy -- Chapter 4 Checkpoint Blockade -- Chapter 5 Myeloid Leukemia…